Xenon Pharmaceuticals (XENE) Deferred Taxes (2018 - 2026)
Xenon Pharmaceuticals (XENE) posted quarterly Deferred Taxes of $447000.0 for Q1 2026, up 136.85% year-over-year from $188726.4 in Q1 2025, and up 140.13% quarter-over-quarter from -$1.1 million in Q4 2025.
Xenon Pharmaceuticals (XENE) Deferred Taxes (2018 - 2026) Analysis & Trends
Xenon Pharmaceuticals (XENE) has reported Deferred Taxes for 9 consecutive years, with $447000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Deferred Taxes rose 136.85% year-over-year to $447000.0; the TTM figure through Mar 2026 stood at -$1.5 million (up 85.32% YoY), while the FY2025 annual figure was -$3.2 million, up 63.92% from the prior year.
- Deferred Taxes rose to $447000.0 in Q1 2026 per XENE's latest filing, from -$1.1 million in the prior quarter.
- Across five years, Deferred Taxes topped out at $447000.0 in Q1 2026 and bottomed at -$8.6 million in Q4 2024.
- Historically, Deferred Taxes has averaged -$703000.0 across 5 years, with a median of -$200000.0 in 2023.
- Annual changes were most pronounced in 2022 — Deferred Taxes soared 2766.67% — and 2024, when it plunged 4206.0%.
- Xenon Pharmaceuticals' Deferred Taxes stood at $5000.0 in 2022, then tumbled by 4100.0% to -$200000.0 in 2023, then slumped by 4206.0% to -$8.6 million in 2024, then jumped by 87.06% to -$1.1 million in 2025, then soared by 140.13% to $447000.0 in 2026.
- Business Quant data shows XENE's Deferred Taxes at $447000.0 in Q1 2026, -$1.1 million in Q4 2025, and -$701000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -69.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 194.40 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -137,876.64 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 2.66 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Xenon Pharmaceuticals | 6.03 Bn | 6.03 Bn | - | -1.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.94 Mn |
| Mar 31, 2026 | 447,000.00 |
| Dec 31, 2025 | -1.11 Mn |
| Sep 30, 2025 | -701,000.00 |
| Jun 30, 2025 | -170,000.00 |
| Mar 31, 2025 | -1.21 Mn |
| Dec 31, 2024 | -8.61 Mn |
| Sep 30, 2024 | -322,000.00 |
| Jun 30, 2024 | -333,000.00 |
| Mar 31, 2024 | 403,000.00 |
| Dec 31, 2023 | -200,000.00 |
| Sep 30, 2023 | -156,000.00 |
| Jun 30, 2023 | -224,000.00 |
| Mar 31, 2023 | 288,000.00 |
| Dec 31, 2022 | 5,000.00 |
| Sep 30, 2022 | -203,000.00 |
| Jun 30, 2022 | -104,000.00 |
| Mar 31, 2022 | 258,000.00 |
| Dec 31, 2021 | 346,000.00 |
| Sep 30, 2021 | -267,000.00 |